The Federal Circuit affirmance eliminates a patent challenge to Apple's speech-recognition technology. While the patent is non-core, the ruling removes a potential licensing cost or design-around risk. Monitor for any petition for rehearing or certiorari by Zentian, though nonprecedential dispositions are rarely reviewed further.
Price Chart
Executive Summary
Two court rulings involving Apple were issued on the same day. In the first, a district court granted a procedural motion to reopen the opposition deadline in a patent case — a routine scheduling order with no merits determination. In the second, the Federal Circuit affirmed the PTAB's final written decision that all claims of Zentian's speech-recognition patent are unpatentable for obviousness, a final win for Apple that removes patent risk on a non-core technology area.
Court Ruling Details
Key Facts
- Federal Circuit affirmed PTAB's final written decision that all claims of U.S. Patent No. 10,062,377 are unpatentable for obviousness
- The '377 patent relates to speech-recognition systems — a non-core technology area for Apple
- District court order in Liu v. Apple is a routine scheduling extension with no merits determination
- Both rulings were issued on September 25, 2026
Financial Impact
No monetary damages or financial exposure stated in either ruling. The patent invalidity ruling removes potential licensing or infringement liability on a speech-recognition patent, but no financial figures were disclosed.
Risk Factors
- Zentian could petition for rehearing en banc or certiorari, though nonprecedential Federal Circuit affirmances are rarely overturned
- Other patent assertions against Apple in speech-recognition or related areas remain possible
Investment Themes
Documents Analyzed
This report is based on 2 court opinions.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-60043ef9f5-AAPL |
| COURT-RULING Data (Synthetic) | court-37f19c1e5b-AAPL |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 5d ago | Insider Cluster | $347.73 | awaiting T+60 | — | $343.91 (−1.10%) |
Oct 22, 2026 5d ago | Court Ruling | $347.73 | awaiting T+60 | — | $343.91 (−1.10%) |
Oct 21, 2026 6d ago | Court Ruling | $348.22 | awaiting T+60 | — | $343.91 (−1.24%) |
Oct 20, 2026 7d ago | Court Ruling | $343.99 | awaiting T+60 | — | $343.91 (−0.02%) |
Oct 19, 2026 7d ago | Insider Cluster | $339.46 | awaiting T+60 | — | $343.91 (+1.31%) |
Oct 19, 2026 8d ago | PTAB Trial | $339.50 | awaiting T+60 | — | $343.91 (+1.30%) |
Oct 19, 2026 8d ago | PTAB Trial | $339.50 | awaiting T+60 | — | $343.91 (+1.30%) |
Oct 15, 2026 11d ago | Institutional Cluster | $342.00 | awaiting T+60 | — | $343.91 (+0.56%) |
Oct 15, 2026 12d ago | Court Ruling | $343.46 | awaiting T+60 | — | $343.91 (+0.13%) |
Oct 13, 2026 14d ago | Court Ruling | $342.96 | awaiting T+60 | — | $343.91 (+0.28%) |
US Market Status
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers